(19)
(11) EP 2 007 423 A2

(12)

(88) Date of publication A3:
20.03.2008

(43) Date of publication:
31.12.2008 Bulletin 2009/01

(21) Application number: 07734181.6

(22) Date of filing: 26.03.2007
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61P 35/00(2006.01)
C07K 16/28(2006.01)
A61P 31/18(2006.01)
(86) International application number:
PCT/IB2007/000860
(87) International publication number:
WO 2007/113648 (11.10.2007 Gazette 2007/41)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 05.04.2006 US 789662 P

(71) Applicant: Pfizer Products Incorporated
Groton, CT 06340 (US)

(72) Inventor:
  • GOMEZ-NAVARRO, Jesus
    Groton, CT 06340 (US)

(74) Representative: Ford, Timothy James 
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) CTLA4 ANTIBODY COMBINATION THERAPY